{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T20:09:41Z","timestamp":1785096581479,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017291","name":"Zhongshan Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bioorg.2025.108180","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:04:52Z","timestamp":1737198292000},"page":"108180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of novel epoxyketone macrocyclic peptidyl proteasome inhibitors through OPA-mediated one-step cyclization of unprotected peptides"],"prefix":"10.1016","volume":"156","author":[{"given":"Gongruixue","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2025.108180_b0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1756-185X.2012.01737.x","article-title":"The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseases","volume":"15","author":"Chitra","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.bioorg.2025.108180_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0305-7372(03)00081-1","article-title":"The proteasome: structure, function, and role in the cell","volume":"29","author":"Adams","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioorg.2025.108180_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107526","article-title":"Exploring the proteasome system: a novel concept of proteasome inhibition and regulation","volume":"211","author":"Wang","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108180_b0020","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1016\/j.jmb.2017.05.027","article-title":"Proteasome structure and assembly","volume":"429","author":"Budenholzer","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108180_b0025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jmcb\/mjq030","article-title":"Structure, assembly and homeostatic regulation of the 26S proteasome","volume":"2","author":"Xie","year":"2010","journal-title":"J. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108180_b0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.str.2014.11.017","article-title":"Crystal structure of the human 20S proteasome in complex with Carfilzomib","volume":"23","author":"Harshbarger","year":"2015","journal-title":"Structure"},{"issue":"3\u20134","key":"10.1016\/j.bioorg.2025.108180_b0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0300-9084(01)01241-X","article-title":"20S proteasome biogenesis","volume":"83","author":"Kr\u00fcger","year":"2001","journal-title":"Biochimie"},{"issue":"40","key":"10.1016\/j.bioorg.2025.108180_b0040","doi-asserted-by":"crossref","first-page":"25200","DOI":"10.1074\/jbc.272.40.25200","article-title":"The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing","volume":"272","author":"Heinemeyer","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108180_b0045","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1021\/acs.jmedchem.9b00101","article-title":"Proteasome activation as a new therapeutic approach to target proteotoxic disorders","volume":"62","author":"Njomen","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108180_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106507","article-title":"Recent advances and future perspectives of noncompetitive proteasome inhibitors","volume":"135","author":"Zeng","year":"2023","journal-title":"Bioorganic Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108180_b0055","first-page":"64","article-title":"The 26S proteasome complex: an attractive target for cancer therapy","volume":"1825","author":"Frankland-Searby","year":"2012","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108180_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106626","article-title":"Exploration of novel four-membered-heterocycle constructed peptidyl proteasome inhibitors with improved metabolic stability for cancer treatment","volume":"138","author":"Wang","year":"2023","journal-title":"Bioorganic Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108180_b0065","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","article-title":"Ubiquitin\u2013proteasome system (UPS) as a target for anticancer treatment","volume":"43","author":"Park","year":"2020","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108180_b0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/14656566.2018.1441287","article-title":"Proteasome inhibitors for the treatment of multiple myeloma","volume":"19","author":"Scalzulli","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108180_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111646","article-title":"Immunoproteasome-selective inhibitors: an overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases","volume":"182","author":"Xi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108180_b0080","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ejmech.2016.10.023","article-title":"Urea-containing peptide boronic acids as potent proteasome inhibitors","volume":"125","author":"Han","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108180_b0085","first-page":"25","article-title":"Effective strategies for improving the stability of peptides in vivo","volume":"55","author":"He","year":"2020","journal-title":"Acta Pharm Sin B."},{"key":"10.1016\/j.bioorg.2025.108180_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114211","article-title":"Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment","volume":"233","author":"Cao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108180_b0095","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1021\/jacs.8b13178","article-title":"Macrocyclic peptides as drug candidates: recent progress and remaining challenges","volume":"141","author":"Vinogradov","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108180_b0100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1021\/cr040669e","article-title":"Proteases universally recognize beta strands in their active sites","volume":"105","author":"Tyndall","year":"2005","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108180_b0105","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/jm1012374","article-title":"Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery","volume":"54","author":"Marsault","year":"2011","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108180_b0110","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrd2590","article-title":"The exploration of macrocycles for drug discovery \u2014 an underexploited structural class","volume":"7","author":"Driggers","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108180_b0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acsmedchemlett.4c00017","article-title":"Macrocyclic oxindole peptide epoxyketones\u2500a comparative study of macrocyclic inhibitors of the 20s proteasome","volume":"15","author":"G\u00f6tz","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108180_b0120","doi-asserted-by":"crossref","first-page":"9177","DOI":"10.1021\/acs.jmedchem.8b00819","article-title":"Development of macrocyclic peptides containing epoxyketone with oral availability as proteasome inhibitors","volume":"61","author":"Li","year":"2018","journal-title":"J. Med. Chem."},{"issue":"31","key":"10.1016\/j.bioorg.2025.108180_b0125","doi-asserted-by":"crossref","first-page":"12274","DOI":"10.1021\/jacs.9b03623","article-title":"Chemoselective peptide cyclization and bicyclization directly on unprotected peptides","volume":"141","author":"Zhang","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108180_b0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T01:54:50Z","timestamp":1758851690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":26,"alternative-id":["S0045206825000604"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108180","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel epoxyketone macrocyclic peptidyl proteasome inhibitors through OPA-mediated one-step cyclization of unprotected peptides","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108180"}}